Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis (PROMESS)
Biplanar MRI for the assessment of the spinal cord in multiple sclerosis.
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Current and future drugs for treatment of MS-associated bladder dysfunction.
Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.
Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up.
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
Successful desensitization to natalizumab in a skin test--positive patient: a case report.
[Cognitive impairment in demyelinating disease].
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
Naltrexone
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE).
Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
Substance Name: Dronabinol
Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
Regional Cervical Cord Atrophy and Disability in Multiple Sclerosis: A Voxel-based Analysis.
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
[Immunodepressive therapy in neurology].
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Pages
« first
‹ previous
…
168
169
170
171
172
173
174
175
176
…
next ›
last »